RNS ARCHIVES

To receive RNS announcements and updates as they are issued please contact intelligentultrasound@walbrookpr.com

Unaudited Preliminary Results for the Year Ended 31 December 2018

Intelligent Ultrasound Group plc (AIM: MED), the artificial intelligence (AI) software and simulation company, announces its unaudited preliminary results for the year ended 31 December 2018, an exciting year for the Group during which it piloted the lead AI obstetric product of its Clinical AI Division and continued to grow sales in its Simulation Division. Financial highlights: • Group revenues (Simulation Division sales only) increased 27% to £5.3m (2017: £4.2m) • Expenditure on R&D up 76% to £1.8m (2017: £1.1m) after significantly increased investment in AI • Raised £4.8m net of costs by way of placing of shares and open [...]

March 28th, 2019|

Intelligent Ultrasound commences partnership with Mediscan Systems to use Artificial Intelligence (AI) and Simulation to improve patient care in India

Intelligent Ultrasound (AIM:MED), today announced that it had commenced a partnership with Mediscan Systems, a premier fetal medicine and ultrasound research & training centre, to use AI and Simulation to improve patient care in India. Intelligent Ultrasound will be supporting Mediscan’s education and training programmes by providing its ScanTrainer advanced ultrasound skills training simulators. ScanTrainer is the only ultrasound skills training simulator to offer curriculum-based teaching using real patient scans with haptic feedback, ScanTutor real-time assisted guidance and comprehensive metric-based assessment in one system. Mediscan’s new simulators will allow it to continue its mission as a leading trainer in ultrasound [...]

March 7th, 2019|

Notice of results

Intelligent Ultrasound Group plc (LSE: MED), the intelligent ultrasound software and simulation company, announces it will issue its final results for the year ended 31 December 2018 on Thursday, 28 March 2019. For further information, click here:  

February 28th, 2019|

Change of name to Intelligent Ultrasound Group plc

MedaPhor Group plc announces that, pursuant to the resolution passed at the General Meeting held on 12 December 2018 (RNS ref: 2840K), it has changed its name to Intelligent Ultrasound Group plc (the "Company" or the "Group"). The Board believes that the new name reflects the fact that the Group is no longer just a global leader in ultrasound training through simulation, but has expanded into the development of artificial intelligence (AI) software to guide and support doctors and sonographers in clinical ultrasound scanning. Trading in the Group's shares under the new name will commence at 8.00 a.m. on 15 [...]

January 14th, 2019|

MedaPhor Group plc Trading Update

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company,   announces that Group turnover for the year to 31 December 2018, which was generated entirely by the Group’s Simulation Division, is expected to grow by approximately 27% to between £5.3m and £5.4m (2017: £4.2m).  The pre-exceptionals EBITDA loss for the year is expected to be around £3m (2017: Loss, £1.7m). This includes approximately £1.5m of primarily R&D expenses attributable to investment in the Group’s Clinical Artificial Intelligence Division which was established with the acquisition of Intelligent Ultrasound Limited (“IUL”) on 6 October 2017 (3 months to 31 December [...]

January 7th, 2019|

Director and PCA Dealings

Further to the Company's announcements on 26 November 2018 and 12 December 2018, MedaPhor announces that certain Directors, persons closely associated (“PCA”) with them and an employee have, following Admission today, acquired a total of 1,847,064 ordinary shares of 1 pence each in the Company ("Ordinary Shares") via the Placing: Click here to view full announcement. Enquiries: investors.medaphor.com/advisors   

December 13th, 2018|

Results of General Meeting and Total Voting Rights

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Accordingly, the Company has raised £5.08 million in the Placing and Open Offer and has issued and allotted 59,750,331 Placing and Open Offer Shares, conditional only on Admission becoming effective. Admission of the Placing and Open Offer Shares is expected at 8.00 a.m. on 13 December 2018. Following Admission, the Company's issued ordinary share capital will comprise 156,627,749 Ordinary Shares, of which none are held in treasury. The above [...]

December 12th, 2018|

Results of Open Offer

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that further to the announcement of the Placing and Open Offer on 26 November 2018, it has conditionally raised total gross proceeds of £78,778 via the Open Offer. The Open Offer closed for acceptances at 11.00 a.m. on 11 December 2018. The Company received valid acceptances from Qualifying Shareholders in respect of 926,801 Open Offer Shares, including applications for 63,354 Open Offer Shares under the Excess Application Facility. This represents 3.8 per cent. of the maximum Open Offer Shares available under the Open Offer. Admission of [...]

December 12th, 2018|